Category: Stem Cell
Global Stem Cell
-
Autologous Cell Therapy Global Market Report 2024
... Cardiovascular Disorders; Autoimmune Disorders; Orthopedics; Wound Healing4) By End User: Hospitals And Clinics; Ambulatory Centers; Academics And ResearchCovering: Bristol-Myers Squibb Company; Novartis AG; Vericel Corporation; Holostem Terapie Avanzate S.r.l.; Pharmicell Co. Ltd. Autologous Cell Therapy ... Read More
-
Exosome Research Market by Product & Service (Kits, Reagents (Antibodies, Isolation Purification), Instruments), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell) - Global Forecast to 2028
... to reach USD 356 million by 2028 from an estimated USD 169 million in 2023, at a CAGR of 16.0% during the forecast period. The growth of this market can be attributed to the increasing ... Read More
-
Immunotherapy Drugs Market (Drug Type: Monoclonal Antibodies, Immunomodulators, Cell Therapy and Others; and Therapy Area: Cancer, Autoimmune Diseases, Infectious Diseases, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Market – Scope of Report TMR’s report on the global immunotherapy drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
CAR T-cell Therapy Market by Indication (Hematologic Malignancies, Solid Tumors), End-Use (Cancer Treatment Centers, Hospitals) - Global Forecast 2024-2030
... to reach USD 5.35 billion in 2024, at a CAGR 5.00% to reach USD 7.15 billion by 2030. Global CAR T-cell Therapy Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Cell Harvesting Market by Type (Automated Cell Harvesters, Manual Cell Harvesters), Application (Biopharmaceutical, Stem Cell Research) - Global Forecast 2024-2030
... to reach USD 2.34 billion in 2024, at a CAGR 8.96% to reach USD 3.98 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cell Harvesting Market. It offers ... Read More
-
Multiple Myeloma Therapeutics Market by Type (Chemotherapy, Radiation, Stem Cell Transplant & Supportive Treatment), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies & Drug Stores) - Global Forecast 2024-2030
... was estimated at USD 21.54 billion in 2023 and expected to reach USD 22.95 billion in 2024, at a CAGR 7.06% to reach USD 34.74 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Cell & Tissue Banking Applications, Clinical Application, Research Applications), End-User - Global Forecast 2024-2030
... USD 2.74 billion in 2023 and expected to reach USD 3.08 billion in 2024, at a CAGR 12.65% to reach USD 6.33 billion by 2030. Global Stem Cell Manufacturing Market FPNV Positioning Matrix The FPNV ... Read More
-
Cell Cryopreservation Market - By Product Type (Cryoprotectant Agents, Equipment), Cell Type (Stem Cells, Oocytes & Embryotic Cells, Sperm Cells), Application (Drug Discovery & Development, Regenerative Medicine), End-use - Global Forecast, 2024 - 2032
... Cell Cryopreservation Market will register a 21.5% CAGR from 2024 to 2032 due to advancements in biobanking technologies and the expanding applications of stem cell research. With the launch of new laboratories, there's an increased ... Read More
-
Stem Cell Assays Market by Product (Instruments, Reagents & Kits), Assay (Apoptosis Assays, Cell Identification Assays, Isolation & Purification Assays), Application - Global Forecast 2024-2030
... 2.75 billion in 2023 and expected to reach USD 3.37 billion in 2024, at a CAGR 22.65% to reach USD 11.52 billion by 2030. Global Stem Cell Assays Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Apoptosis Assays Market by Product (Assay Kits, Instruments, Microplates), Detection Technology (Cell Imaging & Microscopy, Flow Cytometry, Spectrophotometry), Application, End User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 5.82 billion in 2024, at a CAGR 9.63% to reach USD 10.12 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Magnetic Beads Market by Type (Cells & Microbes, Nucleic Acid, Proteins), Application (Antibody Purification, Cell Separation & Expansion, Exosome Analysis), End-Use - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.49 billion in 2024, at a CAGR 9.36% to reach USD 5.93 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Cell & Gene Therapy Market by Product (Cell Therapy, Gene Therapy), Delivery Method (Ex Vivo, In Vivo), Application, End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 34.63 billion in 2024, at a CAGR 25.39% to reach USD 135.04 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Hematological Malignancies Market by Types (Leukemia, Lymphoma, Multiple Myeloma), Treatment (Bone Marrow Transplantation, Chemotherapy, Chimeric Antigen Receptor (Car) T Cell Therapy), Diagnosis, End-Users - Global Forecast 2024-2030
... USD 15.33 billion in 2023 and expected to reach USD 16.84 billion in 2024, at a CAGR 9.92% to reach USD 29.73 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
T-Cell Therapy Market by Modality (Commercialized, Research), Therapy Type (CAR T-cell Therapy, T Cell Receptor-Based, Tumor Infiltrating Lymphocytes-Based), Indication - Global Forecast 2024-2030
... 2023 and expected to reach USD 9.85 billion in 2024, at a CAGR 21.23% to reach USD 31.30 billion by 2030. Global T-Cell Therapy Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Human Organoids Market by Product (Colorectal, Heart, Kidney), Usability (Customizable Products, Ready to Use Products), Application, End-Users - Global Forecast 2024-2030
... expected to reach USD 703.34 million in 2024, at a CAGR 19.94% to reach USD 2,124.91 million by 2030. Global Human Organoids Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Cord Blood Banking Services Market by Services (Processing, Storage), Storage (Private Cord Blood Bank, Public Cord Blood Bank), End-User, Application - Global Forecast 2024-2030
... 32.91 billion in 2023 and expected to reach USD 37.13 billion in 2024, at a CAGR 12.92% to reach USD 77.09 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Acute Lymphoblastic Leukemia Treatment Market (ALL) by Types of Cell (B-cell ALL, Philadelphia chromosome: Positive (Ph+) and negative (Ph-), T-cell ALL), Therapy (Chemotherapy, Radiation Therapy, Stem Cell Transplantation), End-User - Global Forecast 202
... Lymphoblastic Leukemia Treatment Market size was estimated at USD 3.22 billion in 2023 and expected to reach USD 3.42 billion in 2024, at a CAGR 6.45% to reach USD 4.99 billion by 2030. FPNV Positioning ... Read More
-
Advanced Therapy Medicinal Products CDMO Market by Products (Cell Therapy, Gene Therapy, Tissue Engineered), Phase (Phase I, Phase II, Phase III), Indication, End-Users - Global Forecast 2024-2030
... was estimated at USD 7.54 billion in 2023 and expected to reach USD 8.74 billion in 2024, at a CAGR 17.06% to reach USD 22.74 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Thalassemia Treatment Market by Type (Blood Transfusion, Bone Marrow & Stem Cell Transplant, Iron Chelation), Indication Type (Alpha Thalassemia, Beta Thalassemia), End-Users - Global Forecast 2024-2030
... 6.38 billion in 2023 and expected to reach USD 7.06 billion in 2024, at a CAGR 12.31% to reach USD 14.38 billion by 2030. Global Thalassemia Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Transcutaneous Electrical Nerve Stimulation Market by Surgery Procedures (Direct Nerve Repair, Nerve Grafting, Stem Cell Therapy), Product (Desktop, Portable), End User - Global Forecast 2024-2030
... USD 336.69 million in 2023 and expected to reach USD 348.82 million in 2024, at a CAGR 3.69% to reach USD 434.08 million by 2030. Global Transcutaneous Electrical Nerve Stimulation Market FPNV Positioning Matrix The ... Read More
-
Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
... USD 24.01 billion in 2023 and expected to reach USD 28.82 billion in 2024, at a CAGR 20.13% to reach USD 86.73 billion by 2030. Global Regenerative Medicine Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Cell Culture Market by Product (Consumables, Equipment), Application (Biopharmaceutical Production, Cell Banking, Diagnostics) - Global Forecast 2024-2030
... 33.05 billion in 2024, at a CAGR 15.36% to reach USD 77.98 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cell Culture Market. It offers a comprehensive assessment ... Read More
-
Stem Cells Market by Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells), Type (Allogeneic Stem Cell Therapy, Autologous), Therapeutic Application - Global Forecast 2024-
... Market size was estimated at USD 237.23 million in 2023 and expected to reach USD 277.13 million in 2024, at a CAGR 16.91% to reach USD 708.40 million by 2030. Global Stem Cells Market FPNV ... Read More
-
Cell Banking Outsourcing Market by Type (Master Cell Banking, Viral Cell Banking, Working Cell Banking), Cell Type (Non-Stem Cell, Stem Cell), Phase - Global Forecast 2024-2030
... USD 12.64 billion in 2023 and expected to reach USD 14.57 billion in 2024, at a CAGR 15.59% to reach USD 34.87 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Rat & Mouse Model Market by Model Type (Conditioned or Surgically Modified Rats, Genetically Modified Rats, Hybrid or Congenic Rats), Technology (CRISPR, Embryonic Stem Cell Injection, Microinjection), Care Product, Service, Therapeutic Area, End-User - G
... Forecast 2024-2030 The Rat & Mouse Model Market size was estimated at USD 2.26 billion in 2023 and expected to reach USD 2.37 billion in 2024, at a CAGR 5.41% to reach USD 3.27 billion ... Read More
Research Assistance
